Buratuss 5 mg/ml (Pediatric Drops)
15 ml bottle: ৳ 50.00
Medicine Details
Category | Details |
---|---|
Generic | Butamirate citrate |
Company | Beximco pharmaceuticals ltd |
Also available as |
Indications
- Relieves dry cough
- Pre & post-operative cough sedation
- Treatment for acute cough
- Treatment for whooping cough
- Treatment for cough due to respiratory infections
Pharmacology
- Acts directly on the brain's cough center
- Suppresses cough
- Safe and non-sedating
- Rapidly absorbed after oral administration
- Sustained-release tablet
- Antitussive action
Dosage & Administration
- Use in adult:
- Butamirate Citrate 50 mg tablet: 2-3 tablets daily
- Butamirate Citrate syrup: 15 ml 4 times daily
- Use in children & adolescents:
- Butamirate Citrate 50 mg tablet: Adolescent over 12 years old: 1-2 tablets daily
- Butamirate Citrate syrup:
- Children (3-6 yrs): 5 ml 3 times daily
- Children (6-12 yrs): 10 ml 3 times daily
- Adolescent: 15 ml 3 times daily
- Butamirate Citrate pediatric drops:
- Children (2 months-1 yr): 0.50 ml 4 times daily
- Children (1-3 yrs): 0.75 ml 4 times daily
Interaction
Concomitant use with expectorants should be avoided
Contraindications
Hypersensitivity to the active ingredient
Side Effects
- Adverse reactions such as rash
- Nausea
- Diarrhoea
- Vertigo
- Tolerance is good
Pregnancy & Lactation
Should not be used during the first trimester of pregnancy. Caution during remainder of pregnancy. Careful weighing of benefits and risks during breastfeeding.
Precautions & Warnings
- Suppresses the cough reflex
- Concomitant use with expectorants should be avoided
- Consult doctor if cough persists for more than 7 days (more than 3 days in children younger than 12 years)
Overdose Effects
Symptoms may include drowsiness, nausea, vomiting, diarrhoea, loss of balance, and hypotension. Standard emergency procedures should be followed.
Therapeutic Class
Cough suppressant
Storage Conditions
Keep away from light and moisture, store below 30°C. Keep out of the reach of children
Related Brands
- Bucod SR 50 mg (Tablet (Sustained Release)) - sharif-pharmaceuticals-ltd
- Bukof 50 mg (Tablet (Sustained Release)) - beacon-pharmaceuticals-plc
- Deconil SR 50 mg (Tablet (Sustained Release)) - orion-pharma-ltd
- Kofnix SR 50 mg (Tablet (Sustained Release)) - aci-limited
- Mirakof SR 50 mg (Tablet (Sustained Release)) - square-pharmaceuticals-plc